Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Malley currently holds 10,000 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Malley has been a net seller of KNSA stock. They have purchased $5.1M and sold $5.9M worth of shares.
Thomas Malley's most recent insider trade was on Mar 18, 2026, when they sold 10,000 shares at $0.00 per share.
Thomas Malley serves as Executive at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have executed 54 insider transactions totaling $11.0M over their tenure at the company.
Thomas Malley holds the position of Executive at Kiniksa Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Thomas Malley has shown a selling trading pattern, with $5.1M in total purchases and $5.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Malley was on Aug 14, 2025, when they sold $2.6M worth of KNSA shares. This transaction involved 78,233 shares at $33.09 per share.
Thomas Malley currently owns 10,000 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Malley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Malley has 54 Form 4 filings on record as an insider at Kiniksa Pharmaceuticals, Ltd..
Set alerts for Thomas Malley and 40,000+ other insiders.